Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)

NCT02097524 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Sarilumab
DRUG: Tocilizumab

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]